Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab long-term extension in early RA
NCT01649804Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2012
- Primary completion
- Dec 2014
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Jul 2012; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01649804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649804.